RegMedNet

Curious about the recent advancements in tissue engineering? Explore the latest developments offering solutions for real-world applications now >>> hubs.ly/Q047vmjd0

Researchers at Mass General Brigham have developed a novel approach for delivering DNA into cells. In this latest study, their method achieved safe integration without triggering the immune system >>> hubs.ly/Q047vpTW0

This eBook offers foundational knowledge, practical insights and real-world examples to help readers optimize cell culture processes and implement advanced manufacturing systems for cell and gene therapies. Download now >>> hubs.ly/Q043zDlJ0 @Eppendorf_Group

Catch up on the latest news in cell and gene therapy with our weekly round-up >>> hubs.ly/Q046B7rn0 This week: 👉 BioCurie received up to US$9.3 million ARPA-H award for its AI-driven gene therapy manufacturing platform 👉Terumo BCT announced the launch of its cell and gene therapy Ecosystem Blueprint to support developers in the Asia-Pacific region 👉Lonza and Genetix have extended their manufacturing agreement for ZYNTEGLO™

Every month Dusko Ilic answers three quick-fire questions, sharing his expert insights about the latest breakthroughs and trends shaping the field. Curious about what’s making waves this month? Check out his February thoughts here: hubs.ly/Q046b_y30 🔍What was he expecting? ➡️Longevity hype keeps outpacing the evidence ‼️What surprised him? ➡️Japan clears two iPSC therapies with minimal data 📖If we only read one story this month, what should it be? ➡️Medical freedom vs. patient safety: a tale of two stem cell stories

eBook: Bioprocess fundamentals! Whether you're tackling cultivation bottlenecks or exploring automated systems, this eBook provides insight into tools and techniques for better cell culture outcomes and enhanced reproducibility >>> hubs.ly/Q043zCBX0 @Eppendorf_Group

News and views from @biolifesol! Check out their company profile on RegMedNet for the latest in biopreservation media, cell processing tools, and automated thawing systems >>> hubs.ly/Q045HmVq0

Bioprocessing is fundamental in cell and gene therapy development, providing scalable and efficient solutions for cultivating cells and producing therapeutic products. Explore peer-reviewed articles alongside expert guidance and knowledge from @Eppendorf_Group in this eBook >>> hubs.ly/Q043zD9q0

Dusko Ilic shares his expert insights in his latest Industry Updates article >>> bit.ly/4ldRJXt This month’s highlights include: 👉The push for scalable, automated cell therapy manufacturing that’s transforming production paradigms 👉FDA clearance for epigenetic reprogramming therapy, signaling a new era of regulatory openness 👉Renewed focus on AAV safety, reminding us of the importance of long-term vigilance in gene therapy

Bioprocessing is transforming cell and gene therapy with scalable, efficient and reproducible solutions. Discover how to optimize your processes, overcome bottlenecks and implement cutting-edge systems in this eBook, including specially selected content from @Eppendorf_Group >>> hubs.ly/Q043zzRS0

🧠🧬 Breaking barriers in neurodegenerative disorders with gene therapy >>> hubs.ly/Q043-8xd0 In this podcast episode, we had the lovely opportunity to speak with Deborah Ojutalayo, a senior research associate at AviadoBio, to discuss gene therapies for neurodegenerative disorders, with a particular focus on targeted gene therapies for frontotemporal dementia caused by mutations in the GRN gene. Listen to the podcast now!

Catch up on the latest news in cell and gene therapy with our weekly round-up >>> hubs.ly/Q043NY5k0 This week: 👉 NewBiologix announced the publication of a report detailing its HEK293 cell line for optimized rAAV production 👉 Cellares and the @uwsmph expanded their partnership to manufacture CRISPR CAR-T for solid tumors 👉 @JNJNews announced its more than US$1 billion investment in a new US facility for cell therapy manufacturing.

Researchers from Northwestern University have developed the most advanced human spinal cord organoid model to date, enabling the study of spinal cord injuries and testing of a promising regenerative therapy. Read about it here >>> hubs.ly/Q043MDbV0

Bioprocessing is the backbone of innovation across industries like pharmaceuticals, biotechnology, and beyond! This eBook, sponsored by @Eppendorf_Group, is your guide to optimizing culture modes, overcoming bottlenecks, and scaling up with precision. Gain actionable insights to elevate your bioprocessing workflows >>> hubs.ly/Q043zHrN0

Catch up on this weeks cell and gene therapy news with our weekly roundup >>> hubs.ly/Q042R-Dj0

⚛️ Innovating and developing tissue engineering beyond replacement >>> hubs.ly/Q042Qstr0 In this podcast episode for Black History Month, we’re joined by Guillermo Ameer, a professor at @NorthwesternU and Director of the university’s Querrey Simpson Institute for Regenerative Engineering, to discuss the development of innovative biomaterials designed to enhance the body’s healing process. Listen now >>>

Happy International Day of Women and Girls in Science! To celebrate, we’ve curated a selection of books, films and networks that highlight the incredible contributions of women across science, society and culture while addressing the systemic barriers they continue to confront. Whether you’re looking for a good read, a thought-provoking documentary or a place to connect with inspiring people, we’ve got you covered: hubs.ly/Q042DqsN0 #IDWGS #WomenInStem #EveryVoiceInScience

Early phase iPSC therapy trial for Parkinson’s disease >>> hubs.ly/Q042fHft0

For Black History Month, we had the privilege of speaking with Baba Inusa exploring the latest research, advancements, and regenerative approaches for sickle cell disease and thalassemia. Here, Baba also shares insights into ASCAT, an initiative he founded to bring together experts and organizations focused on addressing sickle cell disease, thalassemia and other rare hematological disorders. Listen to the podcast now! hubs.ly/Q0425QnY0

Top stories this week in cell and gene therapy >>> hubs.ly/Q041_jVM0 > A new multi-year agreement for CAR-T therapy manufacturing > Positive long-term data on AAV gene therapy for fatal neurodegenerative disorder > Advocacy groups push to restore Tecartus access